source
- Lexeo Therapeutics acquires Mantle Therapeutics for $8.3M to expand Friedreich ataxia pipelineLexeo Therapeutics announced it will acquire Mantle Therapeutics for an upfront payment of $8.3 million, aiming to broaden its Friedreich ataxia pipeline. The transaction could rise to $21.3 milli…
- Regulators Share Guidance for Effective Sponsor MeetingsRegulators from the U.S. FDA, the U.K. MHRA and other European agencies met to outline best practices for sponsor‑regulator interactions. They highlighted that transparency, open collaboration, at…